Scarica l'app Stockscreener
21.60
0.76%
0.1626
Precedente Chiudi:
$21.44
Aprire:
$20.9
Volume 24 ore:
13,158
Relative Volume:
0.94
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.50%
1M Prestazione:
-3.98%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$20.85
$21.63
Intervallo di 1 settimana:
$20.85
$21.65
Portata 52W:
$20.64
$26.42
Dana Unconstrained Equity Etf Stock (DUNK) Company Profile
Nome
Dana Unconstrained Equity Etf
Settore
Industria
Telefono
-
Indirizzo
-
Compare DUNK vs VTI, SPY, IVV, VB, QQQ
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DUNK
Dana Unconstrained Equity Etf
|
21.60 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.68 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.83 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.91 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.56 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
603.22 | 124.43B | 0 | 0 | 0 | 0.00 |
Dana Unconstrained Equity Etf Borsa (DUNK) Ultime notizie
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients - AOL.com
How well a cancer treatment works may depend on the time of day you get it - AOL.com
Soleus Adds a Significant Number of Celcuity Shares - AOL.com
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition - AOL.com
Gossamer Bio (NASDAQ:GOSS): The High-Stakes Gamble Drawing Big Bank Interest - AOL.com
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes - AOL.com
Warning: This Skyrocketing Stock Has a Hidden Risk - AOL.com
Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies - AOL.com
CSL licenses Eli Lilly's clazakizumab to cut cardiac risk in end-stage kidney disease - AOL.com
Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery - AOL.com
1 Reason I'd Buy Eli Lilly Stock and Never Sell - AOL.com
Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock? - AOL.com
Worst-Performing Stock ETFs - Morningstar
PINK’s 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything - AOL.com
Amazon's Cloud Growth Tied To AI Advances, Analyst Says - Benzinga
3 Best ETFs to Invest In, According to AI Analyst, 12/11/2025 - TipRanks
Why Recursion Pharamaceuticals Topped the Market Today - AOL.com
Dana Investment Advisors, Inc.'s Dana Unconstrained Equity ETF(DUNK) Holding History - GuruFocus
This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy? - AOL.com
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock - AOL.com
Merck secures $700 million funding from Blackstone to develop cancer therapy - AOL.com
Will Tidal Trust I Dana Unconstrained stock benefit from mergers2025 Volatility Report & Expert Curated Trade Setups - newser.com
Eli Lilly Blows Away Q3 Earnings Expectations - AOL.com
ETFs with Netflix, Inc. ( NFLX ) Exposure - ETF Database
Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing - AOL.com
Tidal Trust I Dana Unconstraine (DUNK) Interactive Stock Chart - Yahoo
Tidal Trust I Dana Unconstrained Equity ETF (NYSE:DUNK) Stock Quote - FinancialContent
Eli Lilly: Beyond Weight Loss - AOL.com
DUNK Pivot Points, Technical Analysis and Moving AveragesTidal Trust IDana Unconstrained Equity Etf Technicals - CMLviz
DUNK | Dana Unconstrained Equity ETF Overview - MarketWatch
US ETF launches from 11th to 18th September, 2025 - ETF Express
Dana Investment Dives Into ETFs With Growth And Dividend Funds DUNK And DIVE - Benzinga
UniFirst Corporation Plans to Announce Fourth Quarter Results on October 22, 2025 - The Manila Times
Great-West Lifeco announces offering of Series Z Preferred Shares - The Manila Times
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split - The Manila Times
Dana Investment Advisors Launches Two New ETFs: Dana Unconstrained Equity ETF (DUNK) and Dana Concentrated Dividend ETF (DIVE) - The Manila Times
Investor Reports Highlight Lyno AI Presale Growth as Market Attention Builds - The Manila Times
XRP-Ripple Reports Spotlight MAGACOIN FINANCE After Crossing $14 Million in Presale Funding - The Manila Times
King Copper Discovery Corp. Announces Closing of $15 Million Financing - The Manila Times
Dana Unconstrained Equity ETF Holdings - Quiver Quantitative
Check out Dana Unconstrained Equity ETF's stock price (DUNK) in real time - CNBC
Is Eli Lilly Stock a Buy After Gaining 5% in 1 Day? - AOL.com
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment - AOL.com
GeoWealth: What's New On The Model Marketplace - The Wealth Advisor
What is unconstrained equity investing? - blackrock.com
Top performing managers by category: separate accounts, 4th Quarter 2023 - Pensions & Investments
Zephyr Releases PSN Top Guns List for Q1 2023 Highlighting Best-In-Class Separate Accounts, Managed Accounts and Managed ETF Strategies - Stock Titan
Dana Unconstrained Equity Etf Azioni (DUNK) Dati Finanziari
Non sono disponibili dati finanziari per Dana Unconstrained Equity Etf (DUNK). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):